Endologix Names CFO

Irvine, Calif.-based Endologix Inc., which makes devices for the treatment of aortic disorders, has named Vaseem Mahboob as its new chief financial officer (CFO). Mahboob succeeds Shelley Thunen, who is resigning as part of the company’s previously announced CFO transition.

“We are excited to have Vaseem join the Endologix executive leadership team,” said CEO
John McDermott. “He has deep experience leading the global financial operations of multi-billion dollar healthcare businesses at GE Healthcare, with a track record of improving performance and successfully implementing strategic growth plans. We believe his extensive experience will strengthen our global financial management systems and position us to achieve our long-term growth aspirations.”

Vaseem Mahboob joins Endologix after serving in several financial leadership positions at GE Healthcare, a worldwide leader in medical device development and distribution. His most recent role was chief financial officer of their Global IT business. Prior to this position he was the CFO of their Eastern and African emerging markets where he oversaw financial operations for medical device distribution sales and service spanning 84 countries and four zones including Russia, Turkey, Middle East and Africa. Prior to this role, Mahboob was CFO of GE Healthcare’s Global Ultrasound Business that is the most global and profitable within GE Healthcare. Mahboob also served as CFO of GE Healthcare’s global magnetic resonance (MRI) business, along with several other global financial leadership positions.

Mahboob received a B.A. in engineering from Bangalore Universityin India, and an MBA in financial markets and institutions and information systems from State University of New York, Buffalo, N.Y. He is also a graduate of GE’s highly regarded internal corporate audit staff where he was a senior audit manager.